Compare Heron Therapeutics Inc (HRTX) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Toronto-Dominion Bank — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 3261.4× Heron Therapeutics Inc's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | TD | |
|---|---|---|
Market Cap | $61.47M | $200.48B |
Sector | Health | Financials |
52-Week High | $1.49 | $124.80 |
52-Week Low | $0.32 | $72.85 |
Enterprise Value | $168.21M | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
